Your browser doesn't support javascript.
loading
sTREM-1 as promising prognostic biomarker for acute-on-chronic liver failure and mortality in patients with acute decompensation of cirrhosis.
Yu, Song-Man; Li, Hai; Deng, Guo-Hong; Wang, Xian-Bo; Zheng, Xin; Chen, Jin-Jun; Meng, Zhong-Ji; Zheng, Yu-Bao; Gao, Yan-Hang; Qian, Zhi-Ping; Liu, Feng; Lu, Xiao-Bo; Shi, Yu; Shang, Jia; Chen, Ruo-Chan; Huang, Yan.
Afiliação
  • Yu SM; Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha 410000, Hunan Province, China.
  • Li H; Department of Gastroenterology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  • Deng GH; Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • Wang XB; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100020, China.
  • Zheng X; Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei Province, China.
  • Chen JJ; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  • Meng ZJ; Department of Infectious Disease, Taihe Hospital, Hubei University of Medicine, Shiyan 442009, Hubei Province, China.
  • Zheng YB; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong Province, China.
  • Gao YH; Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
  • Qian ZP; Department of Liver Intensive Care Unit, Shanghai Public Health Clinical Centre, Fudan University, Shanghai 200093, China.
  • Liu F; Tianjin Institute of Hepatology, Nankai University Second People's Hospital, Tianjin 300192, China.
  • Lu XB; Infectious Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China.
  • Shi Y; The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Provine, China.
  • Shang J; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou 463599, Henan Provine, China.
  • Chen RC; Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University, Changsha 110051, Hunan Provine, China.
  • Huang Y; Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University, Changsha 110051, Hunan Provine, China. drhyan@csu.edu.cn.
World J Gastroenterol ; 30(9): 1177-1188, 2024 Mar 07.
Article em En | MEDLINE | ID: mdl-38577193
ABSTRACT

BACKGROUND:

Acute decompensation (AD) of cirrhosis is associated with high short-term mortality, mainly due to the development of acute-on-chronic liver failure (ACLF). Thus, there is a need for biomarkers for early and accurate identification of AD patients with high risk of development of ACLF and mortality. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is released from activated innate immune cells and correlated with various inflammatory processes.

AIM:

To explore the prognostic value of sTREM-1 in patients with AD of cirrhosis.

METHODS:

A multicenter prospective cohort of 442 patients with cirrhosis hospitalized for AD was divided into a study cohort (n = 309) and validation cohort (n = 133). Demographic and clinical data were collected, and serum sTREM-1 was measured at admission. All enrolled patients were followed-up for at least 1 year.

RESULTS:

In patients with AD and cirrhosis, serum sTREM-1 was an independent prognosis predictor for 1-year survival and correlated with liver, coagulation, cerebral and kidney failure. A new prognostic model of AD (P-AD) incorporating sTREM-1, blood urea nitrogen (BUN), total bilirubin (TBil), international normalized ratio (INR) and hepatic encephalopathy grades was established and performed better than the model for end-stage liver disease (MELD), MELD-sodium (MELD-Na), chronic liver failure-consortium (CLIF-C) ACLF and CLIF-C AD scores. Additionally, sTREM-1 was increased in ACLF and predicted the development of ACLF during first 28-d follow-up. The ACLF risk score incorporating serum sTREM-1, BUN, INR, TBil and aspartate aminotransferase levels was established and significantly superior to MELD, MELD-Na, CLIF-C ACLF, CLIF-C AD and P-AD in predicting risk of ACLF development.

CONCLUSION:

Serum sTREM-1 is a promising prognostic biomarker for ACLF development and mortality in patients with AD of cirrhosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Hepática Terminal / Insuficiência Hepática Crônica Agudizada Limite: Humans Idioma: En Revista: World J Gastroenterol / World j. gastroenterol / World journal of gastroenterology Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Hepática Terminal / Insuficiência Hepática Crônica Agudizada Limite: Humans Idioma: En Revista: World J Gastroenterol / World j. gastroenterol / World journal of gastroenterology Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China